CEMAG Consulting becomes CEMAG Care 

CEMAG CARE-1_RVB

Business & Mission

We foster innovative healthcare research projects into viable commercial products (drugs, medtech, biotech).

We support and drive projects internally but also as service provider for third parties, worldwide.

Our customers range from start-up to pharmaceutical companies, including investment funds and foundations.

Project-evaluation-blue

PROJECT EVALUATION & INITIATION

Intuition, experience and pragmatism to analyze innovative scientific ideas & strategical advice to maximize chances of success.

READ MORE
Product-development-blue

PRODUCT DEVELOPMENT

Fostering the development of healthcare innovations through financial and operational support.

READ MORE
Market-strategy-blue

MARKET STRATEGY

Expertise and network for optimum business decision-making.

READ MORE
Project-evaluation

PROJECT EVALUATION & INITIATION

PROJECT ANALYSIS

> Scientific relevance

> Medical targets

> Benchmarking

> KOL consultations

> Regulatory insight

> Business model

DUE DILIGENCE ON

> Team (resources and needs)

> Initial data / Gap Analysis

> Non clinical and clinical development strategy

> Planned development steps and milestones

STRATEGIC ADVICE

> Targeting the right medical indications

> Elaborating development plans

> Regulatory strategy

> Legal advice for company governance

> Identification of potential industrial and financial partners

> Closing of back to back licensing agreements

Product-development

PRODUCT DEVELOPMENT

SUPPORT EXPERTISE - OPERATIONAL IMPLEMENTATION

> Identification of sources of funding

> Project Management (Full or partial)

> Regulatory strategy / guidance / reviews,

> Interactions with regulatory authorities / submissions, …

> Manufacturing, scaling up and industrialization

> Preclinical development

> Clinical development

> Quality Management System

Market-strategy

MARKET STRATEGY

SMART STRATEGICAL ADVICE FOR TARGETING THE HEALTHCARE MARKET

> Identification of potential fast-track indications

> Identification of KOL / experts / organizations operating in the field of proposed indications

> Evaluation of competition

> Pricing constraints and market access

> Definition of business model

> Identification of partners for commercialization

our assets

Who we are

AREAS WHERE WE ARE CURRENTLY ACTIVE

  • null

    > Dermatology & Wound care

    > Tissue Engineering

    > Cellular & Gene Therapy

  • null

    > Women’s health

    > Fertility

  • null

    > Diagnostic

    > Prevention & Handicap

    > Training & loT

SOME PRIVILEGED PARTNERS

OUR NEWS


Welcome to Souhir

Welcome to Souhir

March 2017

 CEMAG Consulting’s new intern :

Souhir Bhiri, PharmD

Product Manager


André Ulmann’s book

André Ulmann's book

March 2017

André Ulmann’s book « Le combat d’un médecin pour les femmes » has just been published (French edition only for the moment).

9791031202143

 


kdog

kdog

22/07/2016

CEMAG Consulting is very happy to further collaborate with Curie Institute regarding cancer detection (Kdog project)

news-kdog

fui project

FUI project

12/07/2016

CEMAG Consulting is part of the WISE Consortium led by Aryballe Technologies. The consortium received the support of bpifrance and Paris Region through FUI grant regarding a project on electronic nose.

news-fui

sme status

SME STATUS

15/04/2016

CEMAG Consulting is qualified as an SME by the EMA (SME Office)

news-sme